The Next 2 Obesity Drug Stocks? Plus, Bitcoin’s Bounce
Barron's Streetwise - Un pódcast de Barron's - Viernes
Categorías:
A top biotech analyst looks beyond Eli Lilly and Novo Nordisk for weight loss investments. Jack talks stocks, bonds, rates, and crypto. Learn more about your ad choices. Visit megaphone.fm/adchoices
